Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
139.9 USD | -0.47% | -1.44% | +6.22% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.22% | 14.14B | |
+9.49% | 114B | |
+13.05% | 107B | |
-6.69% | 22.22B | |
-1.43% | 21.28B | |
-4.55% | 18.8B | |
-6.02% | 17.51B | |
-39.36% | 17.17B | |
+34.71% | 12.2B | |
+16.74% | 8.01B |
- Stock Market
- Equities
- NBIX Stock
- News Neurocrine Biosciences, Inc.
- Goldman Sachs Raises Price Target on Neurocrine Biosciences to $153 From $134, Maintains Buy Rating